IP Library Granted Patent US 10,385,165
Granted Patent B2
US 10,385,165 · App. 15/799,754 · Granted Aug 20, 2019

N-maleimidyl polymer derivatives

Inventor: Xiaoming Shen (Millbrae, CA)
Assignee: Nektar Therapeutics
C08G65/33396A61K31/74A61K47/58A61K47/60A61K47/65C08G65/00C08G65/33337C08G65/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,385,165
App. No.
15/799,754
Granted
Aug 20, 2019
Kind
B2
Abstract

The invention is directed to multi-functional N-maleimidyl polymer derivatives comprising a water soluble and non-peptidic polymer backbone having a terminal carbon, such as a poly(alkylene glycol), the terminal carbon of the polymer backbone being directly bonded to the nitrogen atom of a N-maleimidyl moiety without a linking group therebetween. The invention also provides two methods of preparing such linkerless N-maleimidyl polymer derivatives.

Claims (16)

1. A homobifunctional N-maleimidyl polymer having a formula:

wherein

n is about 20 to about 4000.

2. The homobifunctional N-maleimidyl polymer of claim 1 , wherein the polyethylene glycol backbone has an average molecular weight of from about 800 daltons to about 100,000 daltons.

3. A method of forming a homobifunctional N-maleimidyl polyethylene glycol polymer, the method comprising:

(i) reacting a N-maleimidyl polyethylene glycol amine,

with maleic anhydride to form an open ring amide carboxylic acid intermediate,

wherein the polyethylene glycol backbone of the N-maleimidyl polyethylene glycol amine has an average molecular weight of from about 800 daltons to about 100,000 daltons, and

(ii) heating the open ring amide carboxylic acid intermediate in the presence of acetic anhydride and an acetate salt to thereby form the homobifunctional N-maleimidyl polyethylene glycol polymer,

4. The method of claim 3 , wherein the acetate salt in step (ii) is sodium acetate.

5. The method of claim 3 , wherein the acetate salt in step (ii) is potassium acetate.

6. The method of claim 3 , wherein the heating in step (ii) is at a temperature from about 50° C. to about 140° C.

7. The method of claim 3 , wherein the heating in step (ii) is carried out for about 0.2 hours to about 5 hours.

8. The method of claim 3 , further comprising purifying the homobifunctional N-maleimidyl polyethylene glycol polymer formed in step (ii).

9. The method of claim 8 , wherein the purifying comprises precipitation.

10. The method of claim 8 , wherein the purifying comprises ion exchange chromatography.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 15/835,115 PREVIOUSLY RECORDED AT REEL: 044515 FRAME: 0727. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 10, 2018
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 046762/0412 →
SECURITY INTEREST Recorded Jan 2, 2018
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 044515/0727 →
Continuity (10)
Continuation 15294148 · Oct 14, 2016
Continuation 14865362 · Sep 25, 2015
Continuation 14627917 · Feb 20, 2015
Continuation 14283788 · May 21, 2014
Continuation 13890799 · May 9, 2013
Continuation 11134076 · May 20, 2005
Continuation 10408834 · Apr 7, 2003
Continuation 09790250 · Feb 21, 2001
Provisional Application 60183833 · Feb 22, 2000
Related Publication 20180051135A1 · Feb 22, 2018